StemCyte Taiwan Co., Ltd.
Quick facts
Marketed products
- hUCB · Oncology / Hematology
hUCB is a human umbilical cord blood-derived cell therapy that provides hematopoietic and immunomodulatory support for hematologic reconstitution and immune recovery.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: